- Home
- DEVS vs ALBT Comparison
DEVS vs ALBT Comparison
Compare DEVS & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DEVS
- ALBT
- Stock Information
- Founded
- DEVS N/A
- ALBT 2014
- Country
- DEVS Canada
- ALBT United States
- Employees
- DEVS N/A
- ALBT N/A
- Industry
- DEVS
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DEVS
- ALBT Health Care
- Exchange
- DEVS NYSE
- ALBT Nasdaq
- Market Cap
- DEVS 14.6M
- ALBT 5.3M
- IPO Year
- DEVS N/A
- ALBT N/A
- Fundamental
- Price
- DEVS $0.42
- ALBT $3.41
- Analyst Decision
- DEVS
- ALBT
- Analyst Count
- DEVS 0
- ALBT 0
- Target Price
- DEVS N/A
- ALBT N/A
- AVG Volume (30 Days)
- DEVS 36.9M
- ALBT 12.4K
- Earning Date
- DEVS 07-03-2025
- ALBT 05-13-2025
- Dividend Yield
- DEVS N/A
- ALBT N/A
- EPS Growth
- DEVS N/A
- ALBT N/A
- EPS
- DEVS N/A
- ALBT N/A
- Revenue
- DEVS N/A
- ALBT $807,235.00
- Revenue This Year
- DEVS N/A
- ALBT N/A
- Revenue Next Year
- DEVS N/A
- ALBT N/A
- P/E Ratio
- DEVS N/A
- ALBT N/A
- Revenue Growth
- DEVS N/A
- ALBT N/A
- 52 Week Low
- DEVS $0.18
- ALBT $2.11
- 52 Week High
- DEVS $3.00
- ALBT $12.60
- Technical
- Relative Strength Index (RSI)
- DEVS N/A
- ALBT 37.21
- Support Level
- DEVS N/A
- ALBT $3.40
- Resistance Level
- DEVS N/A
- ALBT $3.79
- Average True Range (ATR)
- DEVS 0.00
- ALBT 0.19
- MACD
- DEVS 0.00
- ALBT -0.02
- Stochastic Oscillator
- DEVS 0.00
- ALBT 1.83
About DEVS DEVVSTREAM CORP
DevvStream Corp is a technology-based ESG company that advances the development and monetization of environmental assets, with an initial focus on carbon markets. It works with governments and corporations to achieve its sustainability goals through the implementation of curated green technology projects that generate renewable energy, improve energy efficiencies, eliminate or reduce emissions, and sequester carbon directly from the air.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.